|
1
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Furnari FB, fenton T, Bachoo RM, Mukasa A,
Stommel JM, Stegh A, Hahn WC, Ligon KL, Louis DN, Brennan C, et al:
Malignant astrocytic glioma: Genetics, biology, and paths to
treatment. Genes Dev. 21:2683–2710. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Stupp R, Hegi ME, Mason WP, van den Bent
MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B,
Belanger K, et al European Organisation for Research and Treatment
of Cancer Brain Tumour and Radiation Oncology Groups; National
Cancer Institute of Canada Clinical Trials Group: Effects of
radiotherapy with concomitant and adjuvant temozolomide versus
radiotherapy alone on survival in glioblastoma in a randomised
phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet
Oncol. 10:459–466. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kim VN: Small RNAs: Classification,
biogenesis, and function. Mol Cells. 19:1–15. 2005.PubMed/NCBI
|
|
6
|
Mendell JT: miRiad roles for the miR-17-92
cluster in development and disease. Cell. 133:217–222. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Subramanian S, Lui WO, Lee CH, Espinosa I,
Nielsen TO, Heinrich MC, Corless CL, Fire AZ and van de Rijn M:
MicroRNA expression signature of human sarcomas. Oncogene.
27:2015–2026. 2008. View Article : Google Scholar
|
|
9
|
Sarver AL, Phalak R, Thayanithy V and
Subramanian S: S-MED: Sarcoma microRNA expression database. Lab
Invest. 90:753–761. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ward A, Balwierz A, Zhang JD, Küblbeck M,
Pawitan Y, Hielscher T, Wiemann S and Sahin Ö: Re-expression of
microRNA-375 reverses both tamoxifen resistance and accompanying
EMT-like properties in breast cancer. Oncogene. 32:1173–1182. 2013.
View Article : Google Scholar
|
|
11
|
Dong L, Li Y, Han C, Wang X, She L and
Zhang H: miRNA microarray reveals specific expression in the
peripheral blood of glioblastoma patients. Int J Oncol. 45:746–756.
2014.PubMed/NCBI
|
|
12
|
Mao XG, Hütt-Cabezas M, Orr BA, Weingart
M, Taylor I, Rajan AK, Odia Y, Kahlert U, Maciaczyk J, Nikkhah G,
et al: LIN28A facilitates the transformation of human neural stem
cells and promotes glioblastoma tumorigenesis through a proinvasive
genetic program. Oncotarget. 4:1050–1064. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Huang Z, Cheng L, Guryanova OA, Wu Q and
Bao S: Cancer stem cells in glioblastoma - molecular signaling and
therapeutic targeting. Protein Cell. 1:638–655. 2010. View Article : Google Scholar
|
|
14
|
Galli R, Binda E, Orfanelli U, Cipelletti
B, Gritti A, De Vitis S, Fiocco R, Foroni C, Dimeco F and Vescovi
A: Isolation and characterization of tumorigenic, stem-like neural
precursors from human glioblastoma. Cancer Res. 64:7011–7021. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Singh SK, Clarke ID, Terasaki M, Bonn VE,
Hawkins C, Squire J and Dirks PB: Identification of a cancer stem
cell in human brain tumors. Cancer Res. 63:5821–5828.
2003.PubMed/NCBI
|
|
16
|
Singh SK, Hawkins C, Clarke ID, Squire JA,
Bayani J, Hide T, Henkelman RM, Cusimano MD and Dirks PB:
Identification of human brain tumour initiating cells. Nature.
432:396–401. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dick JE: Stem cell concepts renew cancer
research. Blood. 112:4793–4807. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bao S, Wu Q, McLendon RE, Hao Y, Shi Q,
Hjelmeland AB, Dewhirst MW, Bigner DD and Rich JN: Glioma stem
cells promote radioresistance by preferential activation of the DNA
damage response. Nature. 444:756–760. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Clement V, Sanchez P, de Tribolet N,
Radovanovic I and Ruiz i Altaba A: HEDGEHOG-GLI1 signaling
regulates human glioma growth, cancer stem cell self-renewal, and
tumorigenicity. Curr Biol. 17:165–172. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lee J, Son MJ, Woolard K, Donin NM, Li A,
Cheng CH, Kotliarova S, Kotliarov Y, Walling J, Ahn S, et al:
Epigenetic-mediated dysfunction of the bone morphogenetic protein
pathway inhibits differentiation of glioblastoma-initiating cells.
Cancer Cell. 13:69–80. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Piccirillo SG, Reynolds BA, Zanetti N,
Lamorte G, Binda E, Broggi G, Brem H, Olivi A, Dimeco F and Vescovi
AL: Bone morphogenetic proteins inhibit the tumorigenic potential
of human brain tumour-initiating cells. Nature. 444:761–765. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nieto MA: The ins and outs of the
epithelial to mesenchymal transition in health and disease. Annu
Rev Cell Dev Biol. 27:347–376. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Savagner P, Yamada KM and Thiery JP: The
zinc-finger protein slug causes desmosome dissociation, an initial
and necessary step for growth factor-induced epithelial-mesenchymal
transition. J Cell Biol. 137:1403–1419. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Thiery JP: Epithelial-mesenchymal
transitions in tumour progression. Nat Rev Cancer. 2:442–454. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yang J and Weinberg RA:
Epithelial-mesenchymal transition: At the crossroads of development
and tumor metastasis. Dev Cell. 14:818–829. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chang CJ, Chao CH, Xia W, Yang JY, Xiong
Y, Li CW, Yu WH, Rehman SK, Hsu JL, Lee HH, et al: p53 regulates
epithelial-mesenchymal transition and stem cell properties through
modulating miRNAs. Nat Cell Biol. 13:317–323. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gravdal K, Halvorsen OJ, Haukaas SA and
Akslen LA: A switch from E-cadherin to N-cadherin expression
indicates epithelial to mesenchymal transition and is of strong and
independent importance for the progress of prostate cancer. Clin
Cancer Res. 13:7003–7011. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hader C, Marlier A and Cantley L:
Mesenchymal-epithelial transition in epithelial response to injury:
The role of foxc2. Oncogene. 29:1031–1040. 2010. View Article : Google Scholar :
|
|
29
|
Lu Y, Chopp M, Zheng X, Katakowski M,
Buller B and Jiang F: MiR-145 reduces ADAM17 expression and
inhibits in vitro migration and invasion of glioma cells. Oncol
Rep. 29:67–72. 2013.
|
|
30
|
Zhang BG, Li JF, Yu BQ, Zhu ZG, Liu BY and
Yan M: microRNA-21 promotes tumor proliferation and invasion in
gastric cancer by targeting PTEN. Oncol Rep. 27:1019–1026.
2012.PubMed/NCBI
|
|
31
|
Zhang HY, Li JH, Li G and Wang SR:
Activation of ARK5/miR-1181/HOXA10 axis promotes
epithelial-mesenchymal transition in ovarian cancer. Oncol Rep.
34:1193–1202. 2015.PubMed/NCBI
|
|
32
|
Yu J, Ryan DG, Getsios S,
Oliveira-Fernandes M, Fatima A and Lavker RM: MicroRNA-184
antagonizes microRNA-205 to maintain SHIP2 levels in epithelia.
Proc Natl Acad Sci USA. 105:19300–19305. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zeppernick F, Ahmadi R, Campos B, Dictus
C, Helmke BM, Becker N, Lichter P, Unterberg A, Radlwimmer B and
Herold-Mende CC: Stem cell marker CD133 affects clinical outcome in
glioma patients. Clin Cancer Res. 14:123–129. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Suvà ML, Riggi N, Janiszewska M,
Radovanovic I, Provero P, Stehle JC, Baumer K, Le Bitoux MA, Marino
D, Cironi L, et al: EZH2 is essential for glioblastoma cancer stem
cell maintenance. Cancer Res. 69:9211–9218. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Li Y, Li A, Glas M, Lal B, Ying M, Sang Y,
Xia S, Trageser D, Guerrero-Câzares H, Eberhart CG, et al: c-Met
signaling induces a reprogramming network and supports the
glioblastoma stem-like phenotype. Proc Natl Acad Sci USA.
108:9951–9956. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Pietras A, Katz AM, Ekström EJ, Wee B,
Halliday JJ, Pitter KL, Werbeck JL, Amankulor NM, Huse JT and
Holland EC: Osteopontin-CD44 signaling in the glioma perivascular
niche enhances cancer stem cell phenotypes and promotes aggressive
tumor growth. Cell Stem Cell. 14:357–369. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chen Y, Meng D, Wang H, Sun R, Wang D,
Wang S, Fan J, Zhao Y, Wang J, Yang S, et al: VAMP8 facilitates
cellular proliferation and temozolomide resistance in human glioma
cells. Neuro Oncol. 17:407–418. 2015.
|
|
38
|
Gielen PR, Aftab Q, Ma N, Chen VC, Hong X,
Lozinsky S, Naus CC and Sin WC: Connexin43 confers Temozolomide
resistance in human glioma cells by modulating the mitochondrial
apoptosis pathway. Neuropharmacology. 75:539–548. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Sun S, Lee D, Ho AS, Pu JK, Zhang XQ, Lee
NP, Day PJ, Lui WM, Fung CF and Leung GK: Inhibition of prolyl
4-hydroxylase, beta polypeptide (P4HB) attenuates temozolomide
resistance in malignant glioma via the endoplasmic reticulum stress
response (ERSR) pathways. Neuro-oncol. 15:562–577. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Polyak K and Weinberg RA: Transitions
between epithelial and mesenchymal states: Acquisition of malignant
and stem cell traits. Nat Rev Cancer. 9:265–273. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zuo JH, Zhu W, Li MY, Li XH, Yi H, Zeng
GQ, Wan XX, He QY, Li JH, Qu JQ, et al: Activation of EGFR promotes
squamous carcinoma SCC10A cell migration and invasion via inducing
EMT-like phenotype change and MMP-9-mediated degradation of
E-cadherin. J Cell Biochem. 112:2508–2517. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Jung H, Lee KP, Park SJ, Park JH, Jang YS,
Choi SY, Jung JG, Jo K, Park DY, Yoon JH, et al: TMPRSS4 promotes
invasion, migration and metastasis of human tumor cells by
facilitating an epithelial-mesenchymal transition. Oncogene.
27:2635–2647. 2008. View Article : Google Scholar
|
|
43
|
Christiansen JJ and Rajasekaran AK:
Reassessing epithelial to mesenchymal transition as a prerequisite
for carcinoma invasion and metastasis. Cancer Res. 66:8319–8326.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Lee RC, Feinbaum RL and Ambros V: The C.
elegans heterochronic gene lin-4 encodes small RNAs with antisense
complementarity to lin-14. Cell. 75:843–854. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Pasquinelli AE, Reinhart BJ, Slack F,
Martindale MQ, Kuroda MI, Maller B, Hayward DC, Ball EE, Degnan B,
Müller P, et al: Conservation of the sequence and temporal
expression of let-7 heterochronic regulatory RNA. Nature.
408:86–89. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Reinhart BJ, Slack FJ, Basson M,
Pasquinelli AE, Bettinger JC, Rougvie AE, Horvitz HR and Ruvkun G:
The 21-nucleotide let-7 RNA regulates developmental timing in
Caenorhabditis elegans. Nature. 403:901–906. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Nakajima G, Hayashi K, Xi Y, Kudo K,
Uchida K, Takasaki K, Yamamoto M and Ju J: Non-coding microRNAs
hsa-let-7g and hsa-miR-181b are associated with chemoresponse to
S-1 in colon cancer. Cancer Genomics Proteomics. 3:317–324.
2006.
|
|
48
|
Ji JF, Zhao L, Budhu AL, et al: Let-7g
targets collagen type I α2 and inhibits cell migration in
hepatocellular carcinoma. Exp Mol Med. 43:298–304. 2011.
|
|
49
|
Xu T, Jiang Y, Yan Y, Wang H, Lu C, Xu H,
Li W, Fu D, Lu Y and Chen J: VSIG4 is highly expressed and
correlated with poor prognosis of high-grade glioma patients. Am J
Transl Res. 7:1172–1180. 2015.PubMed/NCBI
|
|
50
|
Legler JM, Ries LA, Smith MA, Warren JL,
Heineman EF, Kaplan RS and Linet MS: Brain and other central
nervous system cancers: Recent trends in incidence and mortality. J
Natl Cancer Inst. 91:1382–1390. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Garden AS, Maor MH, Yung WK, Bruner JM,
Woo SY, Moser RP and Lee YY: Outcome and patterns of failure
following limited-volume irradiation for malignant astrocytomas.
Radiother Oncol. 20:99–110. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Wang J, Wakeman TP, Lathia JD, Hjelmeland
AB, Wang XF, White RR, Rich JN and Sullenger BA: Notch promotes
radioresistance of glioma stem cells. Stem Cells. 28:17–28.
2010.
|
|
53
|
Kong D, Li Y, Wang Z and Sarkar FH: Cancer
stem cells and epithelial-to-mesenchymal transition
(EMT)-phenotypic cells: Are they cousins or twins? Cancers (Basel).
3:716–729. 2011. View Article : Google Scholar
|
